Published 3-29-2021
FUJIFILM Diosynth Biotechnologies is planning to construct a $2 billion biopharmaceutical production facility in Holly Springs, N.C.
Published 3-15-2021
Foghorn Therapeutics completed construction in March of 2021 on its 60,000-sf headquarters in Kendall Square in Cambridge, Mass.
Published 3-8-2021
Brandywine Realty Trust began construction in March of 2021 on the $287 million West Tower at Schuylkill Yards in Philadelphia.
Published 3-1-2021
Vibalogics is creating a 110,000-sf facility for the production of oncolytic viruses, viral vector vaccines, and viral vector gene therapy products in Boxborough, Mass.
Published 2-22-2021
Thor Sciences is retrofitting an eight-story, 350,000-sf structure to create 95G, a lab-ready research facility in Jersey City.
Published 2-19-2021
Texas Biomedical Research Institute is planning to construct the $10 million Nonhuman Primate Animal Facility in San Antonio.
Published 2-17-2021
The life sciences sector is experiencing an era of unprecedented growth driven by a surge in both public and private funding combined with a post-pandemic sense of urgency and market opportunity. According to a report released by Newmark in January 2021, more than 36 million sf of new construction is expected to be delivered in the nation’s top 14 life science markets, as life science investments more than triple. While demand for life science and biotech facilities has been growing steadily over the past decade, the COVID-19 crisis heightened national awareness around the need for increased research, diagnostic, and domestic manufacturing capabilities. Investors are also seeing significant potential in the future of personalized medicine, genomics, and other life science-related fields, as emerging technologies and research disciplines converge.
Published 2-10-2021
Boylston Properties and J.P. Morgan Asset Management began construction in January of 2021 on a 165,600-sf life sciences facility in Watertown, Mass.
Published 2-5-2021
Civica Rx began construction in early 2021 on a $124.5 million pharmaceutical manufacturing center in Petersburg, Va.
Published 2-1-2021
BioMed Realty is planning to create a life sciences innovation campus in Somerville, Mass.
